AI assistant
EXELIXIS, INC. — Director's Dealing 2019
May 31, 2019
30561_dirs_2019-05-30_a0cc5edf-0ce0-4903-bb91-35a49cc0f124.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2019-05-29
Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-29 | Common Stock | M | 14591 | $7.18 | Acquired | 104591 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-29 | Option (right to buy) | $7.18 | M | 14591 | Acquired | 2019-12-08 | Common Stock (14591.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 193998 | Indirect |
| Common Stock | 17728 | Indirect |
Footnotes
F1: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 28, 2019.
F4: The option, representing the right to purchase a total of 300,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013.